Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding
article
OA: bronze
CC0
⤵ 11 in-corpus citations
Abstract
BACKGROUND: Irregular bleeding affects up to 60% of hormone replacement therapy (HRT) users. The mechanism of this bleeding is not understood. Reduced endometrial microvascular integrity appears to underlie breakthrough bleeding in pre-menopausal women and the aim of this study was to establish whether similar changes are seen in HRT users and hence to elucidate a possible mechanism of irregular bleeding. METHODS: Endometrium from 34 HRT users with amenorrhoea, irregular bleeding or regular bleeding was assessed for endometrial endothelial cell density (anti-CD34), number of blood vessels per mm(2), vascular basal lamina components (laminin, collagen IV and heparan sulphate proteoglycan) and in 32 subjects and 23 controls for perivascular smooth muscle alpha (SMA). Findings were compared with a control population of 29 post-menopausal women not using HRT, other sex steroids or tamoxifen and with no vaginal bleeding. Staining intensity was assessed in a blinded fashion in all immunohistochemical studies. RESULTS: Four significant differences in endometrial blood vessels were observed between HRT users and controls: (i) a significantly lower density of endometrial endothelial cells (EC staining for CD34) per mm(2) was present in HRT users compared with controls (P < 0.001); (ii) endothelial cells (EC) were predominantly organized within blood vessels (83%) in controls but in HRT users EC were dispersed in the tissues with only 29% in organized vessels (P <0.001); (iii) supportive perivascular cell SMA was significantly reduced in 23 post-menopausal HRT users compared with 23 post-menopausal controls (n = 29, P = 0.013) and (iv) an atrophic or inactive histological pattern of endometrium was more frequently seen in the controls (P < 0.001). CONCLUSIONS: These findings support the hypothesis that exposure to HRT profoundly alters endometrial blood vessels, reducing structural integrity thereby predisposing to irregular bleeding in HRT users.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- A longitudinal study of changes in endometrial microvascular density in norplant® implant users via openalex
- Changes in vascular basement membrane in the endometrium of Norplant users via openalex
- Dating the Endometrial Biopsy via openalex
- Hormone replacement therapy and irregular bleeding via openalex
- Hormone replacement therapy and irregular bleeding via openalex
- Oral contraceptive use in perimenopause via openalex
- Perivascular smooth muscle -actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding via openalex
- Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding via openalex
- doi:10.1016/0301-2115(95)02352-6 via openalex
- doi:10.1001/archinte.162.17.1934 via openalex
- doi:10.1126/science.277.5322.55 via openalex
- doi:10.3109/13697139809080677 via openalex
- doi:10.1080/13697130008500127 via openalex
- doi:10.1111/j.1471-0528.1994.tb13180.x via openalex
- doi:10.1016/s0015-0282(98)00047-8 via openalex
- doi:10.1093/humrep/15.10.2075 via openalex
- doi:10.1016/s0301-2115(00)00528-5 via openalex
- doi:10.1067/mob.2000.103092 via openalex
- doi:10.1093/oxfordjournals.humrep.a138268 via openalex
- doi:10.1080/713605198 via openalex
- doi:10.1016/0378-5122(86)90018-6 via openalex
- doi:10.1080/cmt.5.1.45.59 via openalex
- doi:10.1093/humrep/14.10.2609 via openalex
- doi:10.1089/jwh.1997.6.459 via openalex
- doi:10.1016/s0378-5122(01)00282-1 via openalex
- doi:10.1126/science.277.5322.48 via openalex
- doi:10.1093/oxfordjournals.humrep.a136040 via openalex
- doi:10.1016/s0002-9440(10)64899-7 via openalex
- doi:10.3109/13697139909025563 via openalex
Cited by (11)
- Abnormal Bleeding during Menopause Hormone Therapy: Insights for Clinical Management 2013
- Unscheduled bleeding in continuous combined hormone therapy users 2011
- Endometrial bleeding in postmenopausal women 2011
- Abnormal bleeding in postmenopausal hormone users—What do we know today? 2009
- Best Practice & Research Clinical Obstetrics and Gynaecology 2009
- Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels 2008
- Bleeding with menopausal hormone therapy 2008
- Endometrial bleeding during hormone therapy: The effect of progestogens 2007
- Mechanisms of Irregular Bleeding with Hormone Therapy: The Role of Matrix Metalloproteinases and Their Tissue Inhibitors 2006
- Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding 2005
- Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding 2005
Source provenance
- openalex
- last seen: 2026-05-11T06:09:19.794676+00:00
License: CC0
· commercial use OK